How Peptide Purity Is Determined

Purity is a measured quantity, not a property a material simply has. The figure printed on a certificate is the output of a defined procedure, and it means what that procedure is capable of meaning — no more. Understanding how the number is produced is what makes it usable.

HPLC separates a mixture into its components. A small sample is dissolved and driven under pressure through a column packed with a stationary phase while a mobile phase flows past it. Components in the sample interact with the stationary phase to differing degrees, so they travel through the column at different speeds and emerge separately. A detector at the column outlet records what leaves and when.

The output is a chromatogram: a trace with a peak for each separated component. The horizontal position of a peak is its retention time, which is characteristic of the component under those exact conditions. The area beneath a peak is proportional to how much of that component was present.

Reversed-phase separation

Peptide analysis is typically performed in reversed-phase mode, where the stationary phase is non-polar and the mobile phase is polar. Separation is then driven largely by hydrophobicity, which resolves closely related species well. A gradient is usually applied, with the mobile phase composition changing across the run so that both early- and late-eluting components are resolved within a practical time.

For a typical peptide COA, purity is reported as area percent: the area of the main peak divided by the total area of all integrated peaks, expressed as a percentage. A result of 99.2 percent means the main peak accounted for 99.2 percent of the total detected signal in that run.

Two consequences follow directly from that definition. First, the figure is relative to what the detector could see. Anything the detector does not respond to does not appear in the denominator. Second, the figure depends on the integration of the trace — on where peak boundaries were drawn and what was treated as baseline. Both are why the method and its conditions belong on the certificate alongside the number.

Area percent describes the proportion of detected signal, not the proportion of total mass in the vial. The distinction matters when interpreting any purity figure.

Mass spectrometry answers a different question. The sample is ionised and the resulting ions are separated according to their mass-to-charge ratio, producing a spectrum of measured masses. Comparing the observed mass against the expected mass for the target structure is what confirms identity.

Mass spectrometry is well suited to identity confirmation and poorly suited to quantifying relative composition on its own, because different species ionise with different efficiencies. A minor component that ionises readily can produce a large signal, and an abundant one that ionises poorly can produce a small one. Signal intensity therefore does not map cleanly onto abundance.

Each method covers the other's blind spot. HPLC can separate and quantify but cannot, by itself, tell you what a peak is — retention time is suggestive rather than conclusive. Mass spectrometry can identify but cannot reliably quantify relative composition. Run together, the chromatogram establishes how much of the detected material sits in the main peak and the mass spectrum establishes that the main peak is the intended compound.

Both determinations are recorded against the same batch identifier so the two results describe the same physical material. How those fields appear on a certificate is set out in what a certificate of analysis documents.

A specification written as at least 99 percent states a threshold the lot must meet for release under that method. It is a floor, not a description of the remaining fraction, and it is not a claim about anything the method does not measure.

• It means the main peak met or exceeded 99 percent of integrated detected area under the stated method.
• It does not identify what constitutes the remaining fraction.
• It does not describe water content, residual solvent, or counter-ion content unless those are separately reported.
• It does not describe sterility or endotoxin status, which are different tests entirely.
• It does not transfer to another lot, and it does not persist indefinitely once storage conditions change.

Testing performed by a laboratory independent of the party supplying the material removes a structural conflict of interest. The independent laboratory has no stake in the release decision, uses its own instruments and calibration, and reports what it measures. Where an independent result and an in-house result agree, confidence in both increases; where they diverge, the divergence is itself information worth having.

Every analytical method has a detection window. A method sees what it is configured to see and is silent about everything else. Co-elution can hide a species beneath the main peak if separation conditions do not resolve it. Detector response varies between compounds, so equal areas do not always mean equal amounts. Sample preparation can introduce artefacts. None of these are failures of the technique; they are boundaries of it.

The practical response is to treat a purity figure as a specific, bounded statement rather than a general verdict on quality. It applies to one lot, under one method, on one date. It also describes material as tested, which is why post-receipt conditions are treated separately in storage and stability of pre-mixed solutions.